DE

Demant A/SCSE Demant Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

9.085

Middle

Exchange

XCSE - Nasdaq Copenhagen A/S

DEMANT.CO Stock Analysis

DE

Neutral

Based on Eyestock quantitative analysis, DEMANT.CO`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

63/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

38.6 %

Undervalued

Market cap $B

9.085

Dividend yield

Shares outstanding

223.19 B

Demant A/S engages in the development, manufacture, and sale of products and equipment designed to aid the hearing and communication of individuals. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The firm operates globally, through more than 90 subsidiaries and associates worldwide.

View Section: Eyestock Rating